Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Net Margin (2016 - 2025)

Historic Net Margin for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to 7.21%.

  • Marimed's Net Margin fell 47800.0% to 7.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.19%, marking a year-over-year decrease of 22900.0%. This contributed to the annual value of 7.7% for FY2024, which is 30700.0% up from last year.
  • Latest data reveals that Marimed reported Net Margin of 7.21% as of Q3 2025, which was down 47800.0% from 3.21% recorded in Q2 2025.
  • Marimed's Net Margin's 5-year high stood at 23.3% during Q2 2021, with a 5-year trough of 26.06% in Q4 2023.
  • Over the past 5 years, Marimed's median Net Margin value was 2.56% (recorded in 2023), while the average stood at 1.55%.
  • Examining YoY changes over the last 5 years, Marimed's Net Margin showed a top increase of 488000bps in 2021 and a maximum decrease of -514800bps in 2021.
  • Quarter analysis of 5 years shows Marimed's Net Margin stood at 20.64% in 2021, then soared by 164bps to 13.25% in 2022, then tumbled by -297bps to 26.06% in 2023, then rose by 22bps to 20.41% in 2024, then soared by 65bps to 7.21% in 2025.
  • Its Net Margin stands at 7.21% for Q3 2025, versus 3.21% for Q2 2025 and 14.28% for Q1 2025.